National Drug Screening
National Drug Screening is a private outpatient clinical laboratory founded in 1993 in Melbourne, United States, providing on-demand drug and alcohol testing services with 11-50 employees.
- Company typePrivate
- Founded1993
- HeadquartersMelbourne, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What National Drug Screening does
National Drug Screening is a private, for-profit outpatient clinical laboratory founded in 1993 and headquartered in Melbourne, United States. The company provides on-demand drug and alcohol testing services, operating with a headcount of 11-50 employees. It functions as a clinical lab provider within the broader drug screening services market, which is projected to reach $19.2 billion by 2030 at a 14.5% CAGR, implying a sizeable addressable market in which the company participates.
The company's service delivery is centered on clinical laboratory testing for drugs and alcohol, consistent with the occupational health, legal/forensic, and individual consumer segments typical of outpatient drug screening labs. It operates a customer-facing web domain (nationaldrugscreening.com), though the site was inaccessible during data collection — displaying only a Cloudflare/verification loader screen — which materially limits visibility into its specific products, pricing, technology infrastructure, marketing channels, and customer acquisition mechanics. No API, SDK, or software integration footprint is documented.
No revenue, funding history, M&A activity, partnerships, management team, ownership structure, certifications, regulatory actions, product launches, or geographic footprint data is available in the supplied material. The absence of these data points constrains deeper characterization of the company's business model, competitive positioning, customer mix, and growth trajectory, and should be treated as a significant diligence gap rather than a negative signal in itself.
National Drug Screening firmographics
Firmographics- Name
- National Drug Screening
- Website
- https://nationaldrugscreening.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- National Drug Screening is a private outpatient clinical laboratory founded in 1993 in Melbourne, United States, providing on-demand drug and alcohol testing services with 11-50 employees.
- Ownership category
- akta.pro rank
National Drug Screening industry classification
Industry- Product category
- Drug Testing Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)
- akta.pro secondary industries
- Drug & Alcohol Testing Coordination (BPACALAE), Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)
Keywords
Where National Drug Screening is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- United States
- HQ region
- North America
Markets served
National Drug Screening business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
National Drug Screening product offering
Product offeringCore offering
National Drug Screening operates as an outpatient clinical laboratory facility providing on-demand drug and alcohol testing services. The company collects specimens and performs laboratory analysis to deliver screening results for individuals and organizational clients requiring drug and alcohol testing.
Differentiator
Problem solved
Functional benefit
Products and services
- On-Demand Drug and Alcohol Testing Outpatient clinical laboratory drug and alcohol testing services providing specimen collection and analysis for employers, individuals, and organizations requiring certified substance screening.
Companies that use National Drug Screening
Customer profileIdeal customer profiles1 record
National Drug Screening technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
National Drug Screening partnerships and signals
Strategic signalScale indicators1 record
Expansion highlights1 record
National Drug Screening competitors and assessment
Company assessmentBroad incumbents
- Quest Diagnostics: One of the largest US clinical laboratory networks, offering employer drug testing, toxicology, and a full diagnostic menu. It competes directly with National Drug Screening for employer and occupational health toxicology work, but at vastly greater scale and with broader service lines.
- Laboratory Corporation of America (Labcorp): National clinical reference laboratory offering workplace drug testing, toxicology, and routine diagnostics. Comparable to National Drug Screening as a competing toxicology services provider, but operates at national scale with integrated employer solutions.
- Abbott Toxicology / Alere Toxicology (now Abbott): Major diagnostics manufacturer and lab services operator whose toxicology and point-of-care drug testing products compete with the panels and methodologies used by independent drug screening labs like National Drug Screening.
Direct peers
- Concentra: Occupational health and urgent care provider that operates employer-focused drug and alcohol testing services through its clinics and labs. Highly comparable to National Drug Screening given the shared employer/occupational health customer base and drug testing focus.
- Psychemedics Corporation: Specialty laboratory focused exclusively on drug testing using hair analysis, serving employers, courts, and other clients. Comparable to National Drug Screening as a dedicated drug testing lab with a specialty toxicology positioning.
- U.S. Drug Testing Laboratories (USDTL): Specialty toxicology laboratory providing alcohol and drug testing services for workplace, legal, and family-law clients. Directly comparable to National Drug Screening in its outpatient, on-demand toxicology service model.
- Omega Laboratories: Specialty toxicology lab offering hair, nail, and urine drug and alcohol testing for legal, workplace, and personal use. Comparable as a dedicated drug testing laboratory serving similar employer and legal customer segments.
- Cordant Health Solutions: Provides drug testing, medication monitoring, and behavioral health toxicology services to clinicians, employers, and the criminal justice system. Comparable to National Drug Screening as a toxicology-focused lab competing for similar customer segments.
- Clinical Reference Laboratory (CRL): Clinical reference laboratory offering employer drug testing, clinical diagnostics, and specialized toxicology services. Comparable to National Drug Screening in its lab-based drug and alcohol testing service offering to employers and providers.
Emerging players
- eScreen (now part of Abbott): Provider of employer drug screening technology, electronic custody and control forms, and occupational health workflows. Comparable to National Drug Screening as an ecosystem participant serving the same employer drug testing customer base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
National Drug Screening financial estimates
Financial estimateRevenue estimate
Valuation estimate
National Drug Screening leadership team
Management profileNumber of profiles
National Drug Screening funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
National Drug Screening M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about National Drug Screening
What does National Drug Screening do?
National Drug Screening operates as an outpatient clinical laboratory facility providing on-demand drug and alcohol testing services. The company collects specimens and performs laboratory analysis to deliver screening results for individuals and organizational clients requiring drug and alcohol testing.
Is National Drug Screening a public or private company?
National Drug Screening is a private company. It is classified as unknown and is currently operating.
When was National Drug Screening founded?
National Drug Screening was founded in 1993. It employs 11 to 50 people.
Where is National Drug Screening based?
National Drug Screening is headquartered in Melbourne, United States, in the North America region.
Who are National Drug Screening's main competitors?
Broad incumbents on record are Quest Diagnostics, Laboratory Corporation of America (Labcorp) and Abbott Toxicology / Alere Toxicology (now Abbott). Direct peers are Concentra, Psychemedics Corporation, U.S. Drug Testing Laboratories (USDTL), Omega Laboratories, Cordant Health Solutions and Clinical Reference Laboratory (CRL). eScreen (now part of Abbott) is listed as an emerging player.
Does National Drug Screening have an API?
No public API is recorded for National Drug Screening.
What industry is National Drug Screening in?
National Drug Screening's product category is Drug Testing Services. Its primary akta.pro industry code is HLAFAMAF, Toxicology & Therapeutic Drug Monitoring Laboratories, with a secondary code of BPACALAE, Drug & Alcohol Testing Coordination. Its NAICS code is 621511 and its SIC code is 8071.